A high-throughput method for simultaneous profiling of mRNA and protein levels in
A high-throughput method for simultaneous profiling of mRNA and protein levels in
批准号:
8413560
负责人:
MARC Wallace KIRSCHNER
金额:
$26.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2014-08-31
关键词:
Bar CodesBenchmarkingBiologicalBiological AssayCell CountCell CycleCell Differentiation processCell SeparationCellsCharacteristicsClinicalDiseaseDropsDrug resistanceEnsureGenetic TranscriptionHealthHuman GenomeIndividualIntestinesLightMammalian CellMeasurementMeasuresMessenger RNAMetabolismMethodsMolecularMolecular ProfilingMusPerformancePhysiologyPopulationPriceProteinsProtocols documentationPublishingRNARaceReadingReverse Transcriptase Polymerase Chain ReactionReverse TranscriptionRoleRunningSamplingSignal TransductionSpeedStem cellsSystemTechniquesTechnologyTestingTissuesTranscriptWorkcancer cellcancer stem cellcell behaviorcombinatorialcostflexibilityhuman tissueimprovedinsightinterestintestinal cryptnext generationnovelscale upsingle cell analysisstem cell populationsuccesstumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The analysis of individual cells promises to reveal insights into tissue physiology and disease that remain hidden in the study of bulk cell populations. By profiling single cells it is possible to search for rare cell sub- populations with
distinct characteristics, such as drug-resistant cancer cells, which may have profound roles in health and disease. Single cell analysis can also shed light on how cell behavior is controlled, by testing for correlations between the activity of cell signaling, metabolism, cell cycle and cell
differentiation within a tissue. To deliver on the promise of single cell analysis, it is necessaryto satisfy at least four technical requirements. The analysis must be carried out on a large number of cells; it should capture multiple measurements to construct a "cellular profile" or mRNA levels, protein levels, and so on; it should be sufficiently sensitive to detect changes in the profile between different cells; and it should be performed in tissues, or with cells immediately removed from tissues, to ensure that the measurements directly reflect the clinical situation. The problem of scale-up to large numbers of cells is particularly urgent. For example, if drug-resistant cancer cells constitute only 1% of a tumor, then to find even ten such cells requires analyzing 1,000 cells in total. Yet today there is a trade-off between analyzing many cells, and generating a wide cellular profile per cell. Methods that analyze many cells, for example Fluorescent Activated Cell Sorting (FACS), are restricted to a limited number of components and may therefore fail to identify rare cells of interest. Methods that can provide a more comprehensive profile are costly and labor-intensive, and therefore cannot be used on large numbers of cells. An ideal method should generate a cellular profile for <$1 per cell. We propose a method to simultaneously profile over 1,000 cells per run, using widely available sequencing technology. The method combines and adapts a number of existing molecular techniques to measure tens of proteins and 100-200 mRNA levels simultaneously in single cells. This breadth of measurement, particularly of protein levels, is not possible to achieve by any existing system at the single cell level. The method should also be more accurate than the closest comparable technology today, as it requires significantly less signal amplification. The long-term potential of the method is limited primarily by the capabilities of high-throughput sequencing technology, and as sequencing technology continues to improve dramatically in the race to deliver a $1,000 human genome, the cost-efficiency, speed and cell throughput of the method are also expected to improve. We project that this method will eventually cost significantly less than $1 per cell profile. Thus, if successful, this method would provide a profound step forward for single cell analysis.
PUBLIC HEALTH RELEVANCE: A critical limitation facing single cell analysis is the current trade-off between analyzing many cells and many cellular components. We propose a method that overcomes this limitation by profiling the levels of 100-200 mRNA transcripts and tens of proteins in 1,000 or more cells at reasonable cost (~$1/cell) and with few steps. The method combines several established assays, and introduces a novel "combinatorial bar-coding" strategy to simultaneously read out the profile of all cells using next-generation sequencing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The dynamics and underlying mechanisms controlling cell size and canonical Wnt signaling
-
批准号:10670148
-
项目类别:
-
资助金额:$74.92万
-
财政年份:2022
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
The dynamics and underlying mechanisms controlling cell size and canonical Wnt signaling
-
批准号:10797294
-
项目类别:
-
资助金额:$13.3万
-
财政年份:2022
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
The dynamics and underlying mechanisms controlling cell size and canonical Wnt signaling
-
批准号:10405995
-
项目类别:
-
资助金额:$74.92万
-
财政年份:2022
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
Reverse Engineering of Cell Senescence
-
批准号:10573323
-
项目类别:
-
资助金额:$69.39万
-
财政年份:2022
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
Reverse Engineering of Cell Senescence
-
批准号:10365131
-
项目类别:
-
资助金额:$63.84万
-
财政年份:2022
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
Reverse Engineering of Cell Senescence
-
批准号:10445589
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2021
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
Studies of Direct Pluripotent Stem Cell Programming
-
批准号:9091998
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2016
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
Cell Cycle proteomicsin Xenopus
-
批准号:9319402
-
项目类别:
-
资助金额:$20.33万
-
财政年份:2016
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
Cell Cycle proteomicsin Xenopus
-
批准号:8340824
-
项目类别:
-
资助金额:$49.05万
-
财政年份:2012
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
Systems analysis of cell type differentiation in xenopus development
-
批准号:8341917
-
项目类别:
-
资助金额:$65.63万
-
财政年份:2012
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
Cell Cycle proteomicsin Xenopus
-
批准号:8529573
-
项目类别:
-
资助金额:$46.92万
-
财政年份:2012
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
Systems analysis of cell type differentiation in xenopus development
-
批准号:8848093
-
项目类别:
-
资助金额:$60.32万
-
财政年份:2012
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
A high-throughput method for simultaneous profiling of mRNA and protein levels in
-
批准号:8538380
-
项目类别:
-
资助金额:$21.33万
-
财政年份:2012
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
Systems analysis of cell type differentiation in xenopus development
-
批准号:8688292
-
项目类别:
-
资助金额:$61.19万
-
财政年份:2012
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
Systems analysis of cell type differentiation in xenopus development
-
批准号:8539511
-
项目类别:
-
资助金额:$58.88万
-
财政年份:2012
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
Cell Cycle proteomicsin Xenopus
-
批准号:8727071
-
项目类别:
-
资助金额:$49.68万
-
财政年份:2012
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
Systems Analysis of cell type differentiation in Xenopus development
-
批准号:10174971
-
项目类别:
-
资助金额:$61.48万
-
财政年份:2012
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
Cell Cycle proteomicsin Xenopus
-
批准号:8876721
-
项目类别:
-
资助金额:$49.68万
-
财政年份:2012
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
Systems Analysis of cell type differentiation in Xenopus development
-
批准号:10625740
-
项目类别:
-
资助金额:$31.51万
-
财政年份:2012
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
Quantifying post-translational modifications and protein expression by HTP-MS
-
批准号:8046203
-
项目类别:
-
资助金额:$377.85万
-
财政年份:2010
-
负责人:MARC Wallace KIRSCHNER
-
依托单位:
国内基金
海外基金
企业绩效评价的DEA-Benchmarking方法及动态博弈研究
-
批准号:70571028
-
项目类别:面上项目
-
资助金额:16.5万元
-
批准年份:2005
-
负责人:杨印生
-
依托单位: